A pilot study of cabergoline for the treatment of metastatic breast cancer

ConclusionCabergoline was well tolerated, and while the ORR was low, a small subset of patients experienced extended disease control.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research